Study title: Clinical study to investigate the efficacy, safety and immunogenicity of Wilate in children < 6 years of age with inherited von willebrand disease.
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Hemic and Lymphatic Diseases | |||||
| Brands: | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: VON WILLEBRAND FACTOR AND COAGULATION FACTOR VIII IN COMBINATION | |||||
| ATC code: B02BD06 | |||||
| Document link: | |||||
| Document date: | |||||
| Study number: WIL-14 | |||||
| EudraCT number: 2005-001426-84 | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | Y | - | |